- Home
- DRCT vs DARE Comparison
DRCT vs DARE Comparison
Compare DRCT & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRCT
- DARE
- Stock Information
- Founded
- DRCT 2018
- DARE N/A
- Country
- DRCT United States
- DARE United States
- Employees
- DRCT N/A
- DARE N/A
- Industry
- DRCT Computer Software: Programming Data Processing
- DARE Biotechnology: Pharmaceutical Preparations
- Sector
- DRCT Technology
- DARE Health Care
- Exchange
- DRCT Nasdaq
- DARE Nasdaq
- Market Cap
- DRCT 38.7M
- DARE 31.9M
- IPO Year
- DRCT 2022
- DARE N/A
- Fundamental
- Price
- DRCT $1.96
- DARE $3.77
- Analyst Decision
- DRCT Strong Buy
- DARE Strong Buy
- Analyst Count
- DRCT 3
- DARE 4
- Target Price
- DRCT $21.00
- DARE $20.33
- AVG Volume (30 Days)
- DRCT 91.1K
- DARE 60.6K
- Earning Date
- DRCT 11-12-2024
- DARE 11-14-2024
- Dividend Yield
- DRCT N/A
- DARE N/A
- EPS Growth
- DRCT N/A
- DARE N/A
- EPS
- DRCT N/A
- DARE N/A
- Revenue
- DRCT $94,216,000.00
- DARE $2,839,625.00
- Revenue This Year
- DRCT $17.00
- DARE $388.48
- Revenue Next Year
- DRCT $13.27
- DARE $67.37
- P/E Ratio
- DRCT N/A
- DARE N/A
- Revenue Growth
- DRCT N/A
- DARE N/A
- 52 Week Low
- DRCT $1.85
- DARE $3.05
- 52 Week High
- DRCT $35.88
- DARE $7.56
- Technical
- Relative Strength Index (RSI)
- DRCT 37.42
- DARE 49.53
- Support Level
- DRCT $1.85
- DARE $3.42
- Resistance Level
- DRCT $2.67
- DARE $4.22
- Average True Range (ATR)
- DRCT 0.24
- DARE 0.30
- MACD
- DRCT -0.08
- DARE 0.00
- Stochastic Oscillator
- DRCT 13.33
- DARE 35.59
About DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform primarily focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.